Healthcare - Biotechnology - NASDAQ - US
$ 13.98
-5.67 %
$ 1.27 B
Market Cap
-5.12
P/E
CASH FLOW STATEMENT
-195 M
OPERATING CASH FLOW
-98.1 M
INVESTING CASH FLOW
208 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Rocket Pharmaceuticals, Inc.
| Net Income | -246 M |
| Depreciation & Amortization | 7.1 M |
| Capital Expenditures | -16.5 M |
| Stock-Based Compensation | 39.4 M |
| Change in Working Capital | 3.31 M |
| Others | -5.97 M |
| Free Cash Flow | -211 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (245.6) | (221.9) | (169.1) | (139.7) | (77.3) | (74.5) | (29.5) | (42.9) | (68.0) | (9.5) | (7.6) | (6.1) |
| Depreciation & Amortization | 7.1 | 6.3 | 5.4 | 1.1 | 0.4 | 0.3 | 0.2 | 0.2 | 45 K | 0 | 0 | 9 K |
| Deferred Income Tax | 0 | 0 | 3.1 | 1.0 | (1.1) | (0.5) | 0.7 | 0.2 | 46.4 | 0 | 0 | 2 K |
| Stock Based Compensation | 39.4 | 31.0 | 29.2 | 18.6 | 13.4 | 13.6 | 4.0 | 2.9 | 2.4 | 0.2 | (0.1) | 0.5 |
| Other Operating Activities | 0.9 | 0.4 | 13.5 | 29.3 | 3.6 | 2.9 | 0.5 | 0.2 | 1.1 | 1.1 | 0.6 | 0.2 |
| Change in Working Capital | 3.3 | 6.1 | (3.4) | 15.0 | (3.7) | 4.4 | (2.0) | 2.1 | 0.7 | (1.5) | 0.7 | (1.6) |
| Cash From Operations | (194.9) | (178.1) | (121.2) | (74.6) | (64.7) | (53.8) | (26.1) | (37.3) | (17.4) | (9.7) | (6.5) | (6.9) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (16.5) | (8.6) | (7.7) | (29.1) | (23.3) | (1.5) | 70 K | (0.5) | (0.4) | 0 | 0 | 0 |
| Other Items | (81.6) | (60.7) | 26.6 | (67.5) | (15.7) | (3.8) | 75.1 | (65.6) | (31.3) | 0 | 0 | 3 K |
| Cash From Investing Activities | (98.1) | (69.3) | 18.9 | (96.6) | (39.0) | (5.3) | 75.0 | (66.1) | (31.7) | 0 | 0 | 3 K |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 47 K | 0 | 72 K | 0 | (0.7) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48.7 | 13.4 | 0.6 | 7.9 | 2.5 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 7 K | 0 | 0 | 1.7 | (0.3) | 0.1 | 19 K | 0.3 | 0.1 | 8 K | 10.0 | 0 |
| Cash From Financing Activities | 208.4 | 155.3 | 37.7 K | 283.0 | 177.8 | 153.5 | 25.4 K | 16 | 125.5 | 0.6 | 17.9 | 2.5 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | (84.6) | (92.2) | (64.6) | 111.8 | 74.1 | 94.4 | 48.9 | (50.2) | 76.4 | (9.2) | 11.4 | (4.4) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (211.4) | (186.8) | (128.9) | (103.7) | (87.9) | (55.2) | (26.2) | (37.8) | (17.8) | (9.7) | (6.5) | (6.9) |